Stockreport

Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies [Yahoo! Finance]

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations
PDF This development has raised concern about potential approval timing. The FDA has not yet issued a final decision, and the review of Anaphylm remains ongoing. However, [Read more]